Citizen Petition from Americans for Scientific Integrity

An individual is submitting a comment in support of a request for a precautionary neurodevelopmental warning regarding acetaminophen use in infants and young children. The commenter provides a book as a source guide and synthesis of scientific literature regarding the risks of acetaminophen exposure during early brain development.

Allan Peter Davis, representing North Carolina State University, provides toxicogenomic data from the Comparative Toxicogenomics Database (CTD) and AOP-Wiki to support the petition for a pediatric neurodevelopmental warning for acetaminophen. The comment highlights that acetaminophen is a top-ranked chemical association for Autistic Disorder and interacts with multiple biological events in an autism-related adverse outcome pathway.

The Consumer Healthcare Products Association (CHPA) opposes the citizen petition requesting new neurodevelopmental warning language for OTC acetaminophen products. They argue that the petition fails to provide credible evidence of a causal link between postnatal acetaminophen use and autism or other neurodevelopmental outcomes, citing existing scientific literature and regulatory standards.

Americans for Scientific Integrity submitted a Bayesian weight-of-evidence analysis to support their citizen petition for precautionary pediatric acetaminophen warnings. They argue that cumulative evidence from epidemiology, animal models, and biomarkers suggests a risk of neurodevelopmental harm in susceptible children.

Dr. Doron Goldberg, a board-certified OB/GYN, argues that the "Bexsero protocol"—which involves administering prophylactic paracetamol alongside the Bexsero vaccine—is a primary cause of the rising prevalence of autism and ADHD. He advocates for the immediate discontinuation of this protocol, claiming that it would lead to a rapid decline in new ASD cases.

The commenter provides a series of scientific fact sheets and research papers regarding autism spectrum disorder (ASD), focusing on the lack of a link between vaccines and autism and a potential association between acetaminophen exposure and ASD. The submission appears to be a collection of research materials rather than a direct position on the specific citizen petition.

The commenter is a group of academic researchers who submitted a scientific study investigating the effects of paracetamol on human embryonic stem cell neuronal differentiation. Their research provides evidence that paracetamol may play a causal role in impaired neurodevelopment by inducing transcriptional and epigenetic dysregulation.

Kenvue Brands LLC submitted a supplemental response regarding pediatric medical product safety and postmarket monitoring. The comment provides information on FDA's role in monitoring pediatric safety and includes an unrelated scientific study on acetaminophen neurotoxicity.

Kenvue Brands LLC submitted a supplemental response to a citizen petition regarding the safety of prenatal acetaminophen (APAP) exposure. The document provides a detailed review of literature and meta-analyses concerning the association between prenatal APAP use and various neurobehavioral and urogenital outcomes in children.

Kenvue Brands LLC opposes the proposed labeling changes in the Citizen Petition, arguing that the scientific evidence does not support a causal link between acetaminophen and neurodevelopmental disorders. The company provides detailed technical rebuttals to several claims, citing pharmacokinetic data, human and animal studies, and methodological flaws in the petition's cited research.